This page reprints a manufacturer label. Everything below in quotation marks is copied from ATROPINE SULFATE INJECTABLE SOLUTION, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.
This page reprints the FDA label for ATROPINE SULFATE INJECTABLE SOLUTION by Sparhawk Laboratories, Inc, a atropine product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed. 1 other stored label carries the same active ingredient and is listed at the end.
The label
Product: ATROPINE SULFATE INJECTABLE SOLUTION. Manufacturer: Sparhawk Laboratories, Inc. FDA Structured Product Label set id 408c06b2-4f96-4ea2-9d33-2b148fd01884. Label effective 2015-04-20. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.
Indications
For use in Dogs and Cats as an antidote in the treatment of organophosphate insecticide poisoning; to reduce salivation, bronchial secretions or intestinal peristalsis associated with colic or diarrhea, and as a preanesthetic adjuvant.
Dosage and Administration
Dogs and Cats : Inject intravenously, intramuscularly, or subcutaneously, 1 mL for each 20 lbs of body weight as a preanesthetic adjuvant, or to reudce salivation, bronchial secretions, or intestinal peristalsis associated with colic or diarrhea. As an antidote for parasympathomimetic drugs, inject 1 mL for each 5 lbs of body weight administered to effect and repeat as necessary. It is suggested that 1/4 of the dosage be injected intravenously and the remainder intramuscularly or subcutaneously.
Warnings
Poisonous alkaloid. Antidotes: Warmth, Emetics, Cholinergics COMPOSITION Each mL of sterile solution contains: Atropine Sulfate ............................ 0.54 mg Sodium Chloride ................................. 9 mg Benzyl Alcohol .................................. 1.5% Water for Injection ................................ QS Store at controlled room temperature between 15 o and 30 o C (59 o -86 o F) PROTECT FROM LIGHT TAKE TIME OBSERVE LABEL DIRECTIONS SLI Atropine Sulfate SA label
Other labels for this ingredient
These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.
- ATROPINE SULFATE Injections, Covetrus North America. Set id 083cab01-5c45-4ba6-b853-a00084686a8e.
FDA adverse event reports
The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming atropine as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.
These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.
Dogs: 692 reports
| VeDDRA reaction term | Reports |
|---|---|
| Vomiting | 134 |
| Death | 127 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 92 |
| Bradycardia | 83 |
| Cardiac arrest | 75 |
| Anorexia | 66 |
| Other abnormal test result NOS | 61 |
| Lack of efficacy - NOS | 58 |
| Seizure NOS | 54 |
| Death by euthanasia | 47 |
| Tachycardia | 47 |
| Abnormal radiograph finding | 44 |
| Pale mucous membrane | 44 |
| Decreased appetite | 39 |
| Diarrhoea | 39 |
Outcome as recorded by the reporter: Recovered/Normal 256; Ongoing 153; Died 138; Outcome Unknown 85; Euthanized 47; Recovered with Sequela 13.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Cats: 247 reports
| VeDDRA reaction term | Reports |
|---|---|
| Death | 47 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 36 |
| Cardiac arrest | 33 |
| Hypothermia | 28 |
| Behavioural disorder NOS | 27 |
| Other abnormal test result NOS | 27 |
| Dilated pupils | 26 |
| Fever | 23 |
| Vomiting | 22 |
| Not eating | 21 |
| Weight loss | 21 |
| Anorexia | 19 |
| Bradycardia | 19 |
| Elevated blood urea nitrogen (BUN) | 18 |
| Respiratory arrest | 18 |
Outcome as recorded by the reporter: Ongoing 81; Recovered/Normal 70; Died 50; Outcome Unknown 35; Euthanized 14; Recovered with Sequela 1.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Sources
- ATROPINE SULFATE INJECTABLE SOLUTIONFDA · retrieved 2026-09-16
“Dogs and Cats : Inject intravenously, intramuscularly, or subcutaneously, 1 mL for each 20 lbs of body weight as a preanesthetic adjuvant, or to reudce salivation, bronchial secretions, or intestinal peristalsis associated with colic or diarrhea.” (Dosage and Administration)
- openFDA Animal and Veterinary Adverse Event ReportsFDA · retrieved 2026-09-16
Related
From Glarda
The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.